ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,839, issued on March 24, was assigned to ADLAI NORTYE BIOPHARMA Co. LTD. (Zhejiang, China).
"PD-L1 antagonist compound" was invented by Zhiyong Yu (Zhejiang, China), Pan Li (Zhejiang, China), Beidi Xu (Zhejiang, China), Yu Zhou (Zhejiang, China), Wei Pang (Zhejiang, China), Qiaodong Wen (Zhejiang, China), Yongqiang Shi (Zhejiang, China), Zhao Sun (Zhejiang, China) and Meng Lv (Zhejiang, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a compound of Formula (I) and a pharmaceutical composition thereof, as well as a method for using the compounds of Formula (I) to prevent and/or treat immune-related disorders."
The patent was filed ...